Press release
Cancer Biomarkers Market Size, Global Trend and Industry Analysis By Applications and Leading Companies, Forecast By 2027
Request Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/cancer-biomarkers-market-100630
List of Key Cancer Biomarker MarketManufacturers:
Myriad RBM
Abbott
Hoffmann-La Roche Ltd.
BioVision Inc.
Thermo Fisher Scientific
R&D System
Bio-Rad Laboratories, Inc.
Sino Biological Inc.
CENTOGENE N.V.
Sino Biological Inc.
Axon Medchem
Significant Industry Developments of Cancer Biomarkers Market Include:
March 2018 –Oncotype DX AR-V7 nucleus detect test, a predictive and prognostics biomarker was launched by Genomic Health Inc. The test helps in therapeutic decisions among patients who suffer from metastatic castration-resistant prostate cancer (mCRPC) by recognizing a connected variant of the androgen receptor protein namely AR-V7 situated in the nucleus of the circulating tumor cells (CTCs).
November 2018 – A collaborative agreement was signed between AstraZeneca and Biocartis Group NV to obtain molecular diagnostics biomarker for quick results in lung cancer patients across the European region.
Report Highlights
The report offers a comprehensive overview of the market and its prime growth trajectories, such as drivers, restraints, challenges, and opportunities. It throws light on recent oncology biomarker market trends, key industry developments, and other interesting insights. The report emphasizes on the table of segmentation based on factors such as cancer type, biomarker type, end user, and geography. The report discusses the list of players operating in the market and the prime strategies adopted by them to gain a competitive edge in the market. For more information on the report, log on to the company website.
Market Drivers
Rise in Prevalence of Cancer Worldwide to Augment Growth
The increasing prevalence of cancer is a prime factor boosting the cancer biomarkers market growth. In addition to this, the market is also witnessing a significant rise on account of the growing demand for drug discovery and development for various cancer types. Additionally, many pharmaceutical companies are investing massive amounts into research and development of novel biomarkers for cancer therapeutics. Moreover, many clinical trials and pipeline studiesare currently heading towards the end stages of development, and their market entry is likely to attract high cancer biomarkers market revenue in the coming years.
On the flip side, the market may face challenges in terms of reimbursement policies supported by the governments. This is further attributed to the high cost of treatment for cancer,especially indeveloping nations. Nevertheless, government support in spreading awareness about cancer, and the availability of treatment options for the same are likely to create lucrative growth opportunities for the market in the forthcoming years.
Regional Segmentation:
North America to Emerge Dominant Owing to Higher Adoption of Next-Generation Sequencing
From a geographical perspective, the global cancer biomarker market is widespread into the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each of these regions is further categorized into nations. Among these, North America earned USD 6.88 billion in 2018 and emerged dominant owing to the high adoption personalized medicine. Europe ranks second in the market with a rising number of research studies for using biomarkers in development and discovery.
Furthermore, the market in the Asia Pacific is expected to contribute significant oncology biomarker market share on account of rising in investments for research and development of biomarkers. This, coupled with increasing support from government and private bodies for the drug development process and patient stratification.
Competitive Landscape:
Substantial Investment in Research and Development of Novel Therapeutics to Escalate Market Competition
Speak to Analysts in case of any queries:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cancer-biomarkers-market-100630
The global cancer biomarker market is semi-consolidated in nature. Notable players operating in the market are engaging in strategic collaborations such as mergers and acquisitions, joint ventures, company collaborations, and others to gain an edge in the market competition. Apart from this, players are investing massive amounts into research and development of novel therapeutic solutions for various cancer types. Thermo Fisher Scientific, Inc., Abbott, and F. Hoffmann-La Roche Ltd. are currently holding dominant cancer biomarker market shares.
This report focuses on Cancer Biomarkers Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
Cancer Biomarkers Market Highlights of the Report:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Enquire before buying:
https://www.fortunebusinessinsights.com/enquiry/queries/cancer-biomarkers-market-100630
Table of Contents:
Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence/ Incidence, by Cancer Type, by Key Regional/ Countries
New Product Launches, by Key Market Players
Pipeline Analysis, Cancer Biomarkers
Key industry Developments - Mergers, Acquisitions and Partnerships
Global Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Cancer Type
Lung Cancer
Colorectal Cancer
Prostate Cancer
Others
Market Analysis, Insights and Forecast – By Biomarker Type
PSA
HER-2
EGFR
KRAS
Others
Market Analysis, Insights and Forecast – By End User
Pharmaceutical & Biotechnology Companies
Diagnostics & Research Laboratories
Hospitals & Specialty Clinics
Others
Market Analysis, Insights and Forecast – By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
North America Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Cancer Type
Lung Cancer
Colorectal Cancer
Prostate Cancer
Others
Market Analysis, Insights and Forecast – By Biomarker Type
PSA
HER-2
EGFR
KRAS
Others
Market Analysis, Insights and Forecast – By End User
Pharmaceutical & Biotechnology Companies
Diagnostics & Research Laboratories
Hospitals & Specialty Clinics
Others
Market Analysis, Insights and Forecast – By Country/ Sub-region
S.
Canada
Europe Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Cancer Type
Lung Cancer
Colorectal Cancer
Prostate Cancer
Others
Market Analysis, Insights and Forecast – By Biomarker Type
PSA
HER-2
EGFR
KRAS
Others
Market Analysis, Insights and Forecast – By End User
Pharmaceutical & Biotechnology Companies
Diagnostics & Research Laboratories
Hospitals & Specialty Clinics
Others
Market Analysis, Insights and Forecast – By Country/ Sub-region
K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
About Us
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand current competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Size, Global Trend and Industry Analysis By Applications and Leading Companies, Forecast By 2027 here
News-ID: 2545003 • Views: …
More Releases from Fortune Business Insights Pvt. Ltd.
Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% …
The global bread maker market size was valued at USD 7.48 billion in 2023 and is expected to be worth USD 7.70 billion in 2024. The market is projected to reach USD 11.13 billion by 2032, recording a CAGR of 4.71% during the forecast period.
Bread maker machines enable users to create a diverse range of bread at home cost-effectively. The increasing demand for innovative home appliances and the rising replacement…
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Foreca …
The global streetwear market size was valued at USD 325.28 billion in 2023. The market is projected to be worth USD 347.14 billion in 2024 and reach USD 637.13 billion by 2032, exhibiting a CAGR of 7.89% during the forecast period. Asia Pacific dominated the streetwear market with a market share of 36.17% in 2023.
Fortune Business InsightsTM displays this information in a report titled, "Streetwear Market, 2024-2032."
Request a Free Sample…
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Compan …
The streetwear market size was valued at USD 325.28 billion in 2023 and is expected to be worth USD 347.14 billion in 2024. The market is projected to reach USD 637.13 billion by 2032, recording a CAGR of 7.89% during the forecast period.
Streetwear is youth-inspired clothing that is highly popular among hip-hop enthusiasts and skateboarders. It is popular for its vibrant colors, bold logo graphics, and unconventional designs. Streetwear is…
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- …
The global perfume market size was valued at USD 48.05 billion in 2023 and is projected to grow from USD 50.45 billion in 2024 to USD 77.52 billion by 2032, exhibiting a CAGR of 5.51% during the forecast period.
Perfumes are pleasant smelling solutions made by using oils, fragrances, and other ingredients to create a pleasing aroma. Increasing demand for high-quality beauty and grooming products globally is expected to boost the…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
